Christopher Slape

1.3k total citations
29 papers, 970 citations indexed

About

Christopher Slape is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Christopher Slape has authored 29 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Hematology and 7 papers in Oncology. Recurrent topics in Christopher Slape's work include Acute Myeloid Leukemia Research (17 papers), Protein Degradation and Inhibitors (7 papers) and CAR-T cell therapy research (5 papers). Christopher Slape is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Protein Degradation and Inhibitors (7 papers) and CAR-T cell therapy research (5 papers). Christopher Slape collaborates with scholars based in United States, Australia and Belgium. Christopher Slape's co-authors include Peter D. Aplan, Sheryl M. Gough, Ying‐Wei Lin, Zhenhua Zhang, Sarah H. Beachy, Chul Won Choi, Linda Wolff, Helge Hartung, Yang Jo Chung and Mary E. Vail and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Christopher Slape

25 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Slape United States 15 691 513 135 109 104 29 970
Vijay P.S. Rawat Germany 14 614 0.9× 334 0.7× 79 0.6× 96 0.9× 74 0.7× 29 811
Shabnam Kharazi Sweden 12 581 0.8× 391 0.8× 329 2.4× 70 0.6× 80 0.8× 19 937
Karina Eiwen Germany 9 356 0.5× 478 0.9× 116 0.9× 73 0.7× 51 0.5× 20 695
Zhongling Cai United States 6 623 0.9× 666 1.3× 126 0.9× 117 1.1× 86 0.8× 9 966
Anna Kilbey United Kingdom 17 647 0.9× 249 0.5× 163 1.2× 82 0.8× 217 2.1× 35 891
Michelle D. O’Laughlin United States 9 671 1.0× 530 1.0× 75 0.6× 193 1.8× 85 0.8× 13 883
Tihomira I. Todorova United States 10 362 0.5× 307 0.6× 137 1.0× 137 1.3× 64 0.6× 15 661
Sheryl M. Gough United States 12 477 0.7× 231 0.5× 66 0.5× 62 0.6× 90 0.9× 23 658
Takuo Katsumoto Japan 15 721 1.0× 264 0.5× 171 1.3× 96 0.9× 134 1.3× 25 941
Dorothée Selimoglu‐Buet France 13 379 0.5× 354 0.7× 133 1.0× 58 0.5× 108 1.0× 29 692

Countries citing papers authored by Christopher Slape

Since Specialization
Citations

This map shows the geographic impact of Christopher Slape's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Slape with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Slape more than expected).

Fields of papers citing papers by Christopher Slape

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Slape. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Slape. The network helps show where Christopher Slape may publish in the future.

Co-authorship network of co-authors of Christopher Slape

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Slape. A scholar is included among the top collaborators of Christopher Slape based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Slape. Christopher Slape is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lisle, Jessica, et al.. (2021). Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression. Cancers. 13(15). 3858–3858. 1 indexed citations
2.
Slape, Christopher. (2021). Pre-Leukemic States: United by Difference. Cancers. 13(6). 1382–1382.
3.
Shields, Benjamin J., Christopher Slape, Jacob T. Jackson, et al.. (2019). The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1. Leukemia. 33(8). 1868–1880. 12 indexed citations
4.
Guirguis, Andrew A., Christopher Slape, Cédric S. Tremblay, et al.. (2016). PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia. Cell Death and Differentiation. 23(6). 1049–1059. 14 indexed citations
5.
6.
Curtis, David J., et al.. (2013). The fusion partner specifies the oncogenic potential of NUP98 fusion proteins. Leukemia Research. 37(12). 1668–1673. 10 indexed citations
7.
Greenblatt, Sarah, Li Li, Christopher Slape, et al.. (2012). Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model. Blood. 119(12). 2883–2894. 49 indexed citations
8.
Slape, Christopher, Jeremy B. M. Jowett, Peter D. Aplan, et al.. (2012). Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome. Blood. 120(12). 2475–2483. 32 indexed citations
9.
10.
Greenblatt, Sarah, Li Li, Christopher Slape, et al.. (2011). Knock-in of a FLT3 Internal Tandem Duplication Mutation Cooperates with a NUP98-HOXD13 Fusion to Generate Acute Myeloid Leukemia. Blood. 118(21). 865–865.
11.
Gough, Sheryl M., Christopher Slape, & Peter D. Aplan. (2011). NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood. 118(24). 6247–6257. 230 indexed citations
12.
Choi, Chul Won, et al.. (2008). Impaired differentiation and apoptosis of hematopoietic precursors in a mouse model of myelodysplastic syndrome. Haematologica. 93(9). 1394–1397. 16 indexed citations
13.
Chung, Yang Jo, Chul Won Choi, Christopher Slape, Terry J. Fry, & Peter D. Aplan. (2008). Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell. Proceedings of the National Academy of Sciences. 105(37). 14088–14093. 34 indexed citations
14.
Slape, Christopher, Helge Hartung, Ying‐Wei Lin, et al.. (2007). Retroviral Insertional Mutagenesis Identifies Genes that Collaborate with NUP98-HOXD13 during Leukemic Transformation. Cancer Research. 67(11). 5148–5155. 54 indexed citations
15.
Choi, Chul Won, Yang Jo Chung, Christopher Slape, & Peter D. Aplan. (2007). A NUP98-HOXD13 Fusion Gene Impairs Differentiation of T and B Lymphocytes.. Blood. 110(11). 2650–2650.
16.
Cheng, Yue, Zhenhua Zhang, Christopher Slape, & Peter D. Aplan. (2007). Cre-/IoxP-Mediated Recombination between the SIL and SCL Genes Leads to a Block in T-Cell Development at the CD4-CD8- to CD4+CD8+ Transition. Neoplasia. 9(4). 315–321. 3 indexed citations
17.
18.
Slape, Christopher, Lino Tessarollo, & Peter D. Aplan. (2006). Generation of immortal, IL3-dependent cell lines from embryonic stem (ES) cells expressing a NUP98-HOXD13 fusion gene. Cancer Research. 66. 61–61. 1 indexed citations
19.
Lin, Ying-Wei, Mary Barbara, Norman N. Iscove, et al.. (2005). OLIG2 (BHLHB1), a bHLH Transcription Factor, Contributes to Leukemogenesis in Concert with LMO1. Cancer Research. 65(16). 7151–7158. 26 indexed citations
20.
Slape, Christopher & Peter D. Aplan. (2004). The Role of NUP98 Gene Fusions in Hematologic Malignancy. Leukemia & lymphoma. 45(7). 1341–1350. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vijay P.S. Rawat Breakdown of academic impact, for papers by Shabnam Kharazi Breakdown of academic impact, for papers by Karina Eiwen Breakdown of academic impact, for papers by Zhongling Cai Breakdown of academic impact, for papers by Anna Kilbey Breakdown of academic impact, for papers by Michelle D. O’Laughlin Breakdown of academic impact, for papers by Tihomira I. Todorova Breakdown of academic impact, for papers by Sheryl M. Gough Breakdown of academic impact, for papers by Takuo Katsumoto Breakdown of academic impact, for papers by Dorothée Selimoglu‐Buet
Rankless by CCL
2026